| Daysha Rozzay Cooper, RN BSN | |
|
3310 Magnolia St, Orangeburg, SC 29115-1466 | |
| (803) 531-6900 | |
| (803) 531-6907 |
| Full Name | Daysha Rozzay Cooper |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 3310 Magnolia St, Orangeburg, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396309688 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC1500X | Registered Nurse - Community Health | 233933 (South Carolina) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 26741 (South Carolina) | Primary |
| Entity Name | Family Health Centers, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144248451 PECOS PAC ID: 2860305075 Enrollment ID: O20031112000393 |
News Archive
Discovery Laboratories, Inc., a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported that the first patient has been enrolled in the next phase of its phase 2a clinical evaluation of AEROSURF, which is designed to evaluate the safety and tolerability of higher and repeat doses of aerosolized KL4 surfactant administered to premature infants 29 to 34 weeks gestational age (GA) who are receiving nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS), compared to infants receiving nCPAP alone.
During pregnancy, the mother supplies the fetus with nutrients and oxygen via the placenta. If placental development is impaired, this may lead to growth disorders of the embryo or to life-threatening diseases of the mother such as preeclampsia, a serious condition involving high blood pressure and increased urinary protein excretion.
In greater than 90 percent of cases in which treatment for metastatic cancer fails, the reason is that the cancer is resistant to the drugs being used. To treat drug-resistant tumors, doctors typically use multiple drugs simultaneously, a practice called combination therapy.
Physicians do not have sufficient information from clinical trials to understand the risks associated with the prescription of testosterone in older men, according to a Comment in The Lancet Diabetes & Endocrinology, written by Professor Stephanie Page, of the University of Washington and Harborview Medical Center, Seattle, USA.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daysha Rozzay Cooper, RN BSN 3310 Magnolia St, Orangeburg, SC 29115-1466 Ph: (803) 531-6900 | Daysha Rozzay Cooper, RN BSN 3310 Magnolia St, Orangeburg, SC 29115-1466 Ph: (803) 531-6900 |
News Archive
Discovery Laboratories, Inc., a specialty biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, today reported that the first patient has been enrolled in the next phase of its phase 2a clinical evaluation of AEROSURF, which is designed to evaluate the safety and tolerability of higher and repeat doses of aerosolized KL4 surfactant administered to premature infants 29 to 34 weeks gestational age (GA) who are receiving nasal continuous positive airway pressure (nCPAP) for respiratory distress syndrome (RDS), compared to infants receiving nCPAP alone.
During pregnancy, the mother supplies the fetus with nutrients and oxygen via the placenta. If placental development is impaired, this may lead to growth disorders of the embryo or to life-threatening diseases of the mother such as preeclampsia, a serious condition involving high blood pressure and increased urinary protein excretion.
In greater than 90 percent of cases in which treatment for metastatic cancer fails, the reason is that the cancer is resistant to the drugs being used. To treat drug-resistant tumors, doctors typically use multiple drugs simultaneously, a practice called combination therapy.
Physicians do not have sufficient information from clinical trials to understand the risks associated with the prescription of testosterone in older men, according to a Comment in The Lancet Diabetes & Endocrinology, written by Professor Stephanie Page, of the University of Washington and Harborview Medical Center, Seattle, USA.
› Verified 2 days ago
Catherine Simmons, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3310 Magnolia Centers Inc, Orangeburg, SC 29115 Phone: 843-701-6387 | |
Shannon W Easterlin, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 940 Holly St, Orangeburg, SC 29115 Phone: 803-536-2725 Fax: 803-534-3118 | |
Monica Monique Johnson, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3000 Saint Matthews Rd, Orangeburg, SC 29118 Phone: 803-395-2200 | |
Constance Gainey Bailey, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3000 Saint Matthews Rd, Orangeburg, SC 29118 Phone: 803-395-2200 | |
Vincent Bernard Johnson, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3310 Magnolia St, Orangeburg, SC 29115 Phone: 803-531-6900 | |
Ms. Erica Thompson, FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1773 Village Park Drive, Orangeburg, SC 29118 Phone: 803-535-3600 | |
Jennifer Haynes, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 970 Holly St, Orangeburg, SC 29115 Phone: 803-531-2722 Fax: 803-531-2743 |